PTAB Wipes Out Rembrandt's Drug Testing Patent On Remand
In a decision on remand from the Federal Circuit, the Patent Trial and Appeal Board has invalidated five more claims in a Rembrandt Diagnostics LP drug testing patent, reversing an earlier...To view the full article, register now.
Already a subscriber? Click here to view full article